Registry of Lobbyists

12-Month Lobbying Activity Search Results

Search Criteria

  1. Designated public office holder (DPOH) full name: DANIEL MACDONALD
Share this search Create an alert

Refine By

Activity Status Type Subject matter
Government institution of the DPOH
Government Institutions in Registration Summaries

Search Results for the Last 12 Months

Results: 1-12 of 12
    Active Hoffmann-La Roche Limited
    In-house Corporation: BRIGITTE NOLET, PRESIDENT AND CHIEF EXECUTIVE OFFICER
    Monthly Communications: 35
    Active AstraZeneca Canada Inc.
    In-house Corporation: Gaby Bourbara, President
    Monthly Communications: 22
    Active CANADIAN CANCER SOCIETY / Société canadienne du cancer
    In-house Organization: Andrea Seale, Chief Executive Officer
    Monthly Communications: 55
    Active Canadian Life and Health Insurance Association Inc. / Association canadienne des compagnies d'assurances de personnes inc.
    In-house Organization: Stephen Frank, President and Chief Executive Officer
    Monthly Communications: 54
    Active GlaxoSmithKline
    In-house Corporation: Sridhar Venkatesh, General Manager and President
    Monthly Communications: 42
    Active Green Shield Canada
    In-house Organization: Zahid Salman, President and CEO
    Monthly Communications: 22
    Active Gilead Sciences Canada
    In-house Corporation: Christophe Griolet, V.P. and General Manager
    Monthly Communications: 21
    Active Boehringer Ingelheim Canada Ltd.
    In-house Corporation: Mark Lewis, President and CEO
    Monthly Communications: 7
    Active IQVIA Solutions Canada Inc.
    In-house Corporation: Sylvia Durgerian, President
    Monthly Communications: 7
    Active Vertex Pharmaceuticals (Canada) Incorporated
    In-house Corporation: Michael Siauw, General Manager – Canada
    Monthly Communications: 3
    Active RAREi - The Canadian Forum for Rare Disease Innovators / iRARE, le Forum canadien des innovateurs spécialisés dans les maladies rares
    Consultant: WILLIAM DEMPSTER, 3Sixty Public Affairs Inc.
    Monthly Communications: 2
    Active RAREi - The Canadian Forum for Rare Disease Innovators / iRARE, le Forum canadien des innovateurs spécialisés dans les maladies rares
    Consultant: GERALD JEFFCOTT, 3Sixty Public Affairs
    Monthly Communications: 2

Date Modified: